New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Xilio Therapeutics, Inc.
XLO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

41M

Biotechnology

Next Earning date - 13 May 2025

41M

Biotechnology

Next Earning date - 13 May 2025

0.79USD

Shape0.01 ( 0.77%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

43
favorite-chart

Volume Buzz

-96%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

59%

Quote Panel

Shape
Updated March 23, 2025
1W -2.13 % 1M -15.89 % 3M -31.30 % 1Y 12.87 %

Key Metrics

Shape
  • Market Cap

    40.90M


  • Shares Outstanding

    51.77M


  • Share in Float

    16.59M


  • Dividende

    0


  • Earning Date

    13 May 2025


  • Price Target

    0.79


  • Average Volume

    3.99M


  • Beta

    -0.342


  • Range

    0.58-1.93


  • Industry

    Biotechnology


  • Website

    https://www.xiliotx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

XLO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$52M

Shape2909%

2025-Revenue

$0.31

Shape-31%

2025-EPS

$31M

Shape335%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Chardan Capital

initialise

Previous: Not converted

2022-12-21

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.83
vs -0.78

Q2.23

arrow
arrow

N/A

-0.70
vs -0.90

Q3.23

arrow
arrow

N/A

-0.61
vs -0.72

Q4.23

arrow
arrow

N/A

-0.64
vs -0.82

Q1.24

arrow
arrow

N/A

-0.64
vs -0.83

Q2.24

arrow
arrow

N/A

-0.24
vs -0.70

Q3.24

arrow
arrow

N/A

-0.22
vs -0.61

Q4.24

arrow
arrow

N/A

-0.20
vs -0.64

Q1.25

arrow
arrow

+129%

0.19
vs -0.64

Q2.25

arrow
arrow

N/A

-0.20
vs -0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

2.4M  vs NA

Q3.24

arrow
arrow

NA

2.3M  vs NA

Q4.24

arrow
arrow

-41%

1.7M  vs 2.9M

Q1.25

arrow
arrow

NA

23.2M  vs NA

Q2.25

arrow
arrow

+57%

3.7M  vs 2.4M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-25%

-0.25
vs -0.21

Q2.23

arrow
arrow

-29%

-0.29
vs -0.25

Q3.23

arrow
arrow

-32%

-0.32
vs -0.29

Q4.23

arrow
arrow

-48%

-0.48
vs -0.32

Q1.24

arrow
arrow

-67%

-0.67
vs -0.48

Q2.24

arrow
arrow

-42%

-0.42
vs -0.67

Q3.24

arrow
arrow

-67%

-0.67
vs -0.42

Q4.24

arrow
arrow

-74%

-0.74
vs -0.67

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

32

32
vs 28

14%

Q2.23

arrow
arrow

32

32
vs 32

NA

Q3.23

arrow
arrow

31

31
vs 32

-3%

Q4.23

arrow
arrow

33

33
vs 31

6%

Q1.24

arrow
arrow

31

31
vs 33

-6%

Q2.24

arrow
arrow

31

31
vs 31

NA

Q3.24

arrow
arrow

33

33
vs 31

6%

Q4.24

arrow
arrow

34

34
vs 33

3%

Earnings Growth

Latest News